Release of brain–type and heart–type fatty acid–binding proteins in serum after acute ischaemic stroke

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Neurology

• Publication date

  2005-04-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00415-005-0725-zPMID 15834650
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• FUNCTIONAL EVALUATION: THE BARTHEL INDEX.

  2018cited by this paper
• Peripheral markers of blood-brain barrier damage.

  2004cited by this paper
• Brain- and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utility.

  2004cited by this paper
• Fatty Acid Binding Protein as a Serum Marker for the Early Diagnosis of Stroke

  2004cited by this paper
• Early biomarkers of stroke.

  2003cited by this paper
• S100B as a surrogate marker for successful clot lysis in hyperacute middle cerebral artery occlusion

  2003cited by this paper
• Proteins in cerebrospinal fluid and blood: Barriers, CSF flow rate and source-related dynamics

  2003cited by this paper
• S100B and cardiac surgery: Possibilities and limitations

  2003cited by this paper
• AMP-activated protein kinase (AMPK) control of fatty acid and glucose metabolism in the ischemic heart.

  2003cited by this paper
• Brain derived proteins as markers of acute stroke: Their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring

  2003cited by this paper
• Prediction of early clinical severity and extent of neuronal damage in anterior-circulation infarction using the initial serum neuron-specific enolase level.

  2003cited by this paper
• Human Heart-Type Fatty Acid-Binding Protein as an Early Diagnostic and Prognostic Marker in Acute Coronary Syndrome

  2003cited by this paper
• Evaluation of a sandwich enzyme-linked immunosorbent assay for the measurement of serum heart fatty acid-binding protein

  2002cited by this paper
• Protein S-100B: A Serum Marker for Ischemic and Infectious Injury of Cerebral Tissue

  2001cited by this paper
• Fatty acid-binding proteins of nervous tissue

  2001cited by this paper
• Comparison of serum S-100 protein levels following stroke and traumatic brain injury.

  2000cited by this paper
• Release of Glial Tissue–Specific Proteins After Acute Stroke: A Comparative Analysis of Serum Concentrations of Protein S-100B and Glial Fibrillary Acidic Protein

  2000cited by this paper
• Expression of fatty acid binding proteins is altered in aged mouse brain

  1999cited by this paper
• Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage.

  1999cited by this paper
• A sensitive immunoassay for rat fatty acid translocase (CD36) using phage antibodies selected on cell transfectants: abundant presence of fatty acid translocase/CD36 in cardiac and red skeletal muscle and up-regulation in diabetes.

  1999cited by this paper
• Measurement of myocardial infarct size from plasma fatty acid-binding protein or myoglobin, using individually estimated clearance rates.

  1999cited by this paper
• Influence of age and sex and day-to-day and within-day biological variation on plasma concentrations of fatty acid-binding protein and myoglobin in healthy subjects.

  1999cited by this paper
• A sensitive immunoassay for rat fatty acid translocase (CD36) using phage antibodies selected on cell transfectants: abundant presence of fatty acid translocase/CD36 in cardiac and red skeletal muscle and up-regulation in diabetes

  1999cited by this paper
• Fatty acid-binding protein and the early detection of acute myocardial infarction.

  1998cited by this paper
• One-Step Enzyme-Linked Immunosorbent Assay (ELISA) for Plasma Fatty Acid-Binding Protein

  1997cited by this paper
• Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke.

  1997cited by this paper
• S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke.

  1997cited by this paper
• S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction.

  1997cited by this paper
• Serum S-100 Protein, Relationship to Clinical Outcome in Acute Stroke

  1997cited by this paper
• Cellular fatty acid-binding proteins: their function and physiological significance.

  1996cited by this paper
• Isolation and Characterization of Two Fatty Acid Binding Proteins from Mouse Brain

  1996cited by this paper
• Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein.

  1995cited by this paper
• Improved Reliability of the NIH Stroke Scale Using Video Training

  1994cited by this paper
• The expression pattern of a novel gene encoding brain-fatty acid binding protein correlates with neuronal and glial cell development.

  1994cited by this paper
• Brain lipid-binding protein (BLBP): a novel signaling system in the developing mammalian CNS.

  1994cited by this paper
• Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial

  1993cited by this paper
• Modulation of fatty-acid-binding protein content of rat heart and skeletal muscle by endurance training and testosterone treatment

  1992cited by this paper
• Classification and natural history of cerebral infarction

  1992cited by this paper
• Classification and natural history of clinically identifiable subtypes of cerebral infarction.

  1991cited by this paper
• Cellular Fatty Acid-binding Proteins

  1990cited by this paper
• Interobserver agreement for the assessment of handicap in stroke patients.

  1989cited by this paper
• Acinar heterogeneity of fatty acid binding protein expression in the livers of male, female and clofibrate‐treated rats

  1989cited by this paper
• Interobserver agreement for the assessment of handicap in stroke patients.

  1988cited by this paper
• Analysis of the tissue-specific expression, developmental regulation, and linkage relationships of a rodent gene encoding heart fatty acid binding protein.

  1987cited by this paper
• FUNCTIONAL EVALUATION: THE BARTHEL INDEX.

  1965cited by this paper

• Point-of-care testing in ischemic stroke.

  2026cites this paper
• Blood biomarkers to identify patients with different intracranial lesion combinations after traumatic brain injury

  2025cites this paper
• A Panel of Blood Biomarkers for the Diagnosis of Transient Ischemic Attacks

  2025cites this paper
• Knockdown of fatty acid binding protein 3 attenuates cerebral Ischemia-reperfusion injury via inhibiting neuronal apoptosis in mice

  2025cites this paper
• The Role of Fatty Acid Binding Proteins in Neuropsychiatric Diseases: A Narrative Review.

  2025cites this paper
• Biomarker and cognitive decline in atrial fibrillation: a prospective cohort study

  2025cites this paper
• Fatty acid binding protein 3 activates endothelial adhesion of circulating monocytes and impairs endothelial angiogenesis

  2025cites this paper
• H-FABP as a Biomarker in Transient Ischemic Attack

  2024cites this paper
• Management of Pediatric Mild Traumatic Brain Injury Patients: S100b, Glial Fibrillary Acidic Protein, and Heart Fatty-Acid-Binding Protein Promising Biomarkers

  2024cites this paper
• Trajectories of interleukin 10 and heart fatty acid-binding protein levels in traumatic brain injury patients with or without extracranial injuries

  2023cites this paper
• The utility of heart-type free fatty-acid binding-protein (HFABP) levels for differentiating acute ischemic stroke from stroke mimics

  2023cites this paper
• Unlocking the Potential of Stroke Blood Biomarkers: Early Diagnosis, Ischemic vs. Haemorrhagic Differentiation and Haemorrhagic Transformation Risk: A Comprehensive Review

  2023cites this paper
• Diagnostic and Prognostic Blood Biomarkers in Transient Ischemic Attack and Minor Ischemic Stroke: An Up-To-Date Narrative Review.

  2022cites this paper
• Biomarker Development in Cardiology: Reviewing the Past to Inform the Future

  2022cites this paper
• Circulating Biomarkers in Long-Term Stroke Prognosis: A Scoping Review Focusing on the South African Setting

  2022cites this paper
• Fatty Acid-Binding Proteins: Their Roles in Ischemic Stroke and Potential as Drug Targets

  2022cites this paper
• Neurovascular Unit-Derived Extracellular Vesicles: From Their Physiopathological Roles to Their Clinical Applications in Acute Brain Injuries

  2022cites this paper
• Effects of Pulsed Field Ablation on Autonomic Nervous System in Paroxysmal Atrial Fibrillation: A Pilot Study.

  2022cites this paper
• Fatty Acid-Binding Protein 3 and CXC-Chemokine Ligand 16 are Associated with Unfavorable Outcome in Aneurysmal Subarachnoid Hemorrhage.

  2021cites this paper
• Biomarkers, Clinical Variables, and the CHA2DS2-VASc Score to Detect Silent Brain Infarcts in Atrial Fibrillation Patients

  2021cites this paper
• Cerebrospinal fluid heart fatty acid‐binding protein as a predictive biomarker of neurodegeneration in Alzheimer’s disease

  2021cites this paper
• Heart-type fatty acid-binding protein: an overlooked cardiac biomarker

  2020cites this paper
• Prognostic utility of heart-type fatty acid-binding protein in patients with stable coronary artery disease and impaired glucose metabolism: a cohort study

  2020cites this paper
• Transient Ischemic Attack: Timely Diagnosis and Early Intervention

  2020cites this paper
• Heart-type fatty acid binding protein predicts cardiovascular events in patients with stable coronary artery disease: a prospective cohort study

  2020cites this paper
• Title: Fatty Acid-Binding Protein 3 in Cerebrospinal Fluid of Hip Fracture Patients with Delirium Authors/affiliations:

  2020cites this paper
• Fatty Acid-Binding Protein 3 in Cerebrospinal Fluid of Hip Fracture Patients with Delirium

  2020cites this paper
• Neurovascular Unit as a Source of Ischemic Stroke Biomarkers—Limitations of Experimental Studies and Perspectives for Clinical Application

  2019cites this paper
• [Heart - type fatty acid binding protein in prognosis of ischemic stroke at the hospital stage].

  2019cites this paper
• Astrocyte-derived fatty acid-binding protein 7 protects blood-brain barrier integrity through a caveolin-1/MMP signaling pathway following traumatic brain injury.

  2019cites this paper
• Serum biomarkers in patients suspected of transient ischaemic attack in primary care: a diagnostic accuracy study

  2019cites this paper
• Fatty Acid Signaling Mechanisms in Neural Cells: Fatty Acid Receptors

  2019cites this paper
• Blood biomarkers in ischemic stroke: potential role and challenges in clinical practice and research

  2018cites this paper
• The use of serum hypoxia-inducible factor two alpha levels and diagnostic values in adult carbon monoxide poisoning

  2018cites this paper
• The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease

  2018cites this paper
• A multivariate predictive modeling approach reveals a novel CSF peptide signature for both Alzheimer's Disease state classification and for predicting future disease progression

  2017cites this paper
• Fatty acid binding protein 4 is associated with stroke risk and severity in patients with acute ischemic stroke.

  2017cites this paper
• Circulating FABP4 (Fatty Acid–Binding Protein 4) Is a Novel Prognostic Biomarker in Patients With Acute Ischemic Stroke

  2017cites this paper
• Effect of carotid endarterectomy on brain damage markers

  2017cites this paper
• The association between FABP7 serum levels with survival and neurological complications in acetaminophen-induced acute liver failure: a nested case–control study

  2017cites this paper
• H-FABP: A new biomarker to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury

  2017influential citation
• Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trial

  2017cites this paper
• Fatty acid transporting proteins: Roles in brain development, aging, and stroke.

  2017cites this paper
• Current Issues in Pharmacy and Medical Sciences

  2017cites this paper
• Urinary liver-type fatty acid binding protein is an independent predictor of stroke and mortality in individuals with type 1 diabetes

  2017cites this paper
• Serum heart type fatty acid binding protein levels are not changed in hyperthyroidism.

  2016cites this paper
• Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke

  2016cites this paper
• Serum biomarkers for the early diagnosis of TIA: The MIND-TIA study protocol

  2015cites this paper
• Cerebrospinal Fluid Fatty Acid-Binding Protein 3 is Related to Dementia Development in a Population-Based Sample of Older Adult Women Followed for 8 Years

  2015cites this paper
• RETRACTED ARTICLE: Relationship of Serum Heart-Type Fatty Acid-Binding Protein Levels and Cerebral Infarction: a Meta-analysis

  2015cites this paper
• Current and future bioanalytical approaches for stroke assessment.

  2015cites this paper
• The SafeBoosC II randomized trial: treatment guided by near-infrared spectroscopy reduces cerebral hypoxia without changing early biomarkers of brain injury

  2015cites this paper
• The Diagnostic Value of Brain-Fatty Acid Binding Protein in Traumatic Brain Injury

  2014cites this paper
• Cardiovascular Abnormalities in Carbon Monoxide Poisoning

  2014cites this paper
• Proteomic and biomarker studies and neurological complications of pediatric sickle cell disease

  2014cites this paper
• Increased H-FABP concentrations in nonalcoholic fatty liver disease

  2013cites this paper
• Antagonism of P2Y1‐induced vasorelaxation by acyl CoA: a critical role for palmitate and 3′‐phosphate

  2013cites this paper
• Heart-fatty acid-binding and tau proteins relate to brain injury severity and long-term outcome in subarachnoid haemorrhage patients.

  2013cites this paper
• Predictive value of circulating interleukin-6 and heart-type fatty acid binding protein for three months clinical outcome in acute cerebral infarction: multiple blood markers profiling study

  2013cites this paper
• Plasma heart-type fatty acid binding protein level in acute ischemic stroke: comparative analysis with plasma S100B level for diagnosis of stroke and prediction of long-term clinical outcome.

  2013cites this paper
• The Prognostic Significance of the Serum Biomarker Heart-Fatty Acidic Binding Protein in Comparison with S100b in Severe Traumatic Brain Injury

  2013cites this paper
• Limited clinical value of multiple blood markers in the diagnosis of ischemic stroke.

  2013cites this paper
• Usefulness of heart-type fatty acid binding protein in the emergency department.

  2013cites this paper
• Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer’s disease

  2013cites this paper
• Heart-type fatty acid-binding protein as a potential biomarker of acute carbon monoxide poisoning.

  2013cites this paper
• Clinically Relevant Biomarkers for Myocardial Infarction

  2012cites this paper
• Panels of biomarkers to improve patient classification in brain diseases

  2012cites this paper
• Evolving role of biomarkers in acute cerebrovascular disease

  2012cites this paper
• Is there a relationship between serum heart- type fatty acid binding protein level and clinical severity in patients with subarachnoid hemorrhage?

  2012cites this paper
• Evaluation of the relationship between heart type fatty acid binding protein levels and the risk of maternal cardiac ischemia in low risk obstetric population during delivery.

  2012cites this paper
• Heart-Fatty Acid-Binding Protein as a Marker for Early Detection of Acute Myocardial Infarction and Stroke

  2012cites this paper
• Brain‐specific fatty acid‐binding protein is elevated in serum of patients with dementia‐related diseases

  2011cites this paper
• Brain lipid-binding protein: a marker of differentiation in neuroblastic tumors.

  2011cites this paper
• Brain protection in cardiac surgery

  2011cites this paper
• The role of heart-type fatty acid-binding protein in the evaluation of carbon monoxide poisoning in rats

  2011cites this paper
• Biochemical Markers of Brain Injury

  2011cites this paper
• Modeling of Pathological Traits in Alzheimer's Disease Based on Systemic Extracellular Signaling Proteome*

  2011cites this paper
• Isobaric tagging-based selection and quantitation of cerebrospinal fluid tryptic peptides with reporter calibration curves.

  2010cites this paper
• Serum heart-type fatty acid binding protein levels in acromegaly patients

  2010cites this paper
• Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment.

  2010cites this paper
• Clinical application of blood biomarkers in cerebrovascular disease

  2010cites this paper
• Ischemia-modified albumin and heart fatty acid-binding protein: could early ischemic cardiac biomarkers be used in acute stroke management?

  2010cites this paper
• Effects of low and high intensity exercises on serum mean values of myoglobin and heart-type fatty acid-binding protein in athletes

  2010cites this paper
• A multiparameter panel method for outcome prediction following aneurysmal subarachnoid hemorrhage

  2009cites this paper
• H-FABP in the early diagnosis of stroke

  2009cites this paper
• Serum heart type fatty acid binding protein levels in metabolic syndrome

  2009cites this paper
• Sustained release of neuron-specific enolase to serum in amateur boxers

  2009cites this paper
• Serum free hemoglobin as a novel potential biomarker for acute ischemic stroke

  2009cites this paper
• Molecular biomarkers in stroke diagnosis and prognosis.

  2009cites this paper
• Identification of Cardiac Myosin-binding Protein C as a Candidate Biomarker of Myocardial Infarction by Proteomics Analysis*

  2009cites this paper
• Brain natriuretic peptide correlates with the extent of atrial fibrillation-associated silent brain lesions.

  2008cites this paper
• Increased levels of CSF heart-type fatty acid-binding protein and tau protein after aneurysmal subarachnoid hemorrhage.

  2008cites this paper
• CSF biomarkers for improved prognostic accuracy in acute CNS disease

  2007cites this paper
• Serum Heart-Type Fatty Acid-Binding Protein and Cerebrospinal Fluid Tau: Marker Candidates for Dementia with Lewy Bodies

  2007cites this paper
• Evaluation of S100A10, annexin II and B‐FABP expression as markers for renal cell carcinoma

  2007cites this paper
• Identification of brain cell death associated proteins in human post-mortem cerebrospinal fluid.

  2006cites this paper
• Stroke biomarkers: Can they help us to guide stroke thrombolysis?

  2006cites this paper
• Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome.

  2006cites this paper
• Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma

  2006cites this paper
• Detection of brain injury by fatty acid-binding proteins

  2005cites this paper